about
Role of chemotherapy in nasopharyngeal carcinomaImpact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy.Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significanceNormal tissues toxicities triggered by combined anti-angiogenic and radiation therapies: hurdles might be aheadRadiotherapy for localized rectal cancer.Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.A PPAR-gamma agonist protects from radiation-induced intestinal toxicity.Role of the PPAR-γ system in normal and tumoral pituitary corticotropic cells and adrenal cells.Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature.Hypofractionation in prostate cancer: radiobiological basis and clinical appliance.Radiotherapy in the age of cancer immunology: Current concepts and future developments.A PPAR-gamma agonist attenuates pulmonary injury induced by irradiation in a murine model.Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience.Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.External beam radiotherapy in thyroid carcinoma: clinical review and recommendations of the AIRO "Radioterapia Metabolica" Group.Treatment of invasive male breast cancer: a 40-year single-institution experience.Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model.Differential effect triggered by a heparan mimetic of the RGTA family preventing oral mucositis without tumor protection.The CXCR4/CXCL12 axis in endometrial cancer.Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy.Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer.Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial.Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases.Impact of sentinel node tumor burden on outcome of invasive breast cancer patients.Neoadjuvant treatment of soft tissue sarcoma.Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a single-institution experience.Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival.Outcome after conservative surgery and breast irradiation in 5,717 patients with breast cancer: implications for supraclavicular nodal irradiation.Radiotherapy timing in 4,820 patients with breast cancer: university of florence experience.Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review.Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice.From a waiting list to a priority list: a computerized model for an easy-to-manage and automatically updated priority list in the booking of patients waiting for radiotherapy.Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice.A new standardized data collection system for interdisciplinary thyroid cancer management: Thyroid COBRA.Cutaneous and cardiac toxicity of concurrent trastuzumab and adjuvant breast radiotherapy: a single institution series.Cyberknife stereotactic radiosurgery for the re-irradiation of brain lesions: a single-centre experience.Impact of a breathing-control system on target margins and normal-tissue sparing in the treatment of lung cancer: experience at the radiotherapy unit of Florence University.
P50
Q27022454-9CF60A03-4134-44B5-B131-CF7A017E937CQ30240601-035B7579-091C-4A22-BA53-5E6952D17CEFQ33876719-E959A964-0189-4AE2-85D2-D4792F8A35AAQ34020601-7948EBEC-2AC7-4C29-85AC-3BAE5C3CA038Q36089944-A0CA3002-E13E-4382-B9B7-EF1FA0202A06Q36881968-6F341910-33A5-4F72-84F1-247DF4E081C2Q37176540-525B116D-F166-4AE6-AFB6-C0B800EB41A8Q37321944-B5321F2C-5420-4FF3-8BD2-DF81AF525863Q37698546-F68F3D7D-0904-435A-850F-EAA112699FB6Q37786919-FDF68269-F74C-4868-BCFA-48F759C8F6B5Q38214480-3EA6B086-FF5D-4459-92D8-1E07D666166BQ38226822-1954A80D-6574-438B-850A-B4A09F28D5A6Q38742020-F2E4851B-FA98-4EAD-A78F-2C74F16515EDQ38801239-942F9DEF-1D70-48C2-817B-359AA83FCD31Q38897959-BF8A71F2-31F9-4262-90E1-36E64619D4A2Q38913042-729168E1-628D-4718-AC6E-5F68915CD048Q38959267-337FD096-63E1-4D23-B226-7A7AD05EEBCBQ39572831-5A9C4CD6-3CDA-4AEE-93C6-22F8A124788DQ39768197-090CAD3F-FDBE-4069-9A72-F68512603BF6Q39834813-9358F4BA-6D2A-44F0-A76A-4E5C6048E1F7Q39886658-2F45AD79-EFB9-4BAE-8BCA-2CD2C7EDEA89Q40505371-5C403B29-5ED3-465C-86A4-5F75F357A21EQ41385767-7E1CD05C-27B9-407F-B444-DFFD66EFC54CQ41387966-B987B0BF-457B-4D42-A302-57738BEEBE58Q43236882-33F3412B-7E60-4125-B3CE-EDAAE8531033Q43458062-4C1C42EE-68B8-47E2-A8DF-8138ACCC4B5EQ43587647-75E472AA-652C-447A-95B7-4970F5A0821FQ43709885-2FDF30DD-B7AB-46A6-8F54-0F3FCEB0C07EQ44948248-B812F474-D06F-4910-9638-40E1BB85A62EQ45844676-C12E237F-637D-48DE-9975-C2599EADE0A8Q45962037-11E1455A-FD80-4FAB-9707-8130395D5E04Q46420260-DE589747-3342-4E5F-822D-93819A948245Q47378837-26D25F38-AA48-4ECE-AB3E-BAA82EBB260DQ47385024-0B605CB9-7D2F-4805-9168-1D02EACD55BAQ48173407-0ECC8AC7-663C-42DC-8CFD-3487EFA4D005Q48318268-CEDD4664-94C0-413C-A7E3-39F132B2BF02Q50422004-9E4347D8-F82D-4F52-99B9-E40F4AE9862DQ50720975-43A8995B-4167-4FFF-BA3F-4E2483F4D064Q50728750-36756FDF-A635-4E45-B71C-5006FE2C7489Q50753662-E546ADC4-95DE-4F9E-B4B4-0A8CBCA6951B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Monica Mangoni
@ast
Monica Mangoni
@en
Monica Mangoni
@es
Monica Mangoni
@nl
type
label
Monica Mangoni
@ast
Monica Mangoni
@en
Monica Mangoni
@es
Monica Mangoni
@nl
altLabel
monica mangoni
@en
prefLabel
Monica Mangoni
@ast
Monica Mangoni
@en
Monica Mangoni
@es
Monica Mangoni
@nl
P1053
K-8142-2016
P106
P1153
7003873024
P21
P31
P496
0000-0002-3422-6812